Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography

被引:78
作者
Lee, SH
Yoo, SD
Lee, KH
机构
[1] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea
[2] Choongwae Pharma Co, Formulat Res Lab, Hwasung Kun 445970, Kyunggi Do, South Korea
来源
JOURNAL OF CHROMATOGRAPHY B | 1999年 / 724卷 / 02期
关键词
paclitaxel;
D O I
10.1016/S0378-4347(98)00566-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This report describes a rapid, simple and sensitive isocratic high-performance liquid chromatography with diode array UV detection for micro-sample analysis of paclitaxel in mouse plasma. The analysis utilized a Capcell-pak octadecyl analytical column and a mobile phase consisting of acetonitrile-0.1% phosphoric acid in deionized water (55:45, v/v). Paclitaxel and n-hexyl p-hydroxybenzoic acid (internal standard) were extracted from plasma by one-step extraction with tert.-butyl methyl ether. Peak purity was determined over a UV wavelength range of 200 to 400 nm. Paclitaxel and the internal standard were eluted at 3.4 min and 5.4 min, respectively, at a mobile phase flow-rate of 1.3 ml/min. No interfering peaks were observed and the total run time was 10 min. The standard curve was linear (r=0.9999) over the concentration range of 0.010-500 mu g/ml. The extraction recovery was >90% for both paclitaxel and n-hexyl p-hydroxybenzoic acid. The intra- and inter-day assay variabilities of paclitaxel ranged from 0.4 to 2.2% and 0.6 to 7.8%, respectively. The LOD and LOQ were 5 and 10 ng/ml, respectively, for paclitaxel using a plasma sample volume of 100 mu l. This highly sensitive and simple assay method was successfully applied to a pharmacokinetic study after i.v. administration of paclitaxel 20 mg/kg to mice. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:357 / 363
页数:7
相关论文
共 27 条
[1]  
BITCH F, 1993, J CHROMATOGR, V615, P273
[2]   EXPEDIENT LIQUID-CHROMATOGRAPHIC ASSAY FOR PACLITAXEL IN PLASMA AFTER ITS ADMINISTRATION TO CANCER-PATIENTS [J].
ELYAZIGI, A ;
YUSUF, A .
THERAPEUTIC DRUG MONITORING, 1995, 17 (05) :511-515
[3]   NONLINEAR PHARMACOKINETICS AND METABOLISM OF PACLITAXEL AND ITS PHARMACOKINETIC/PHARMACODYNAMIC RELATIONSHIPS IN HUMANS [J].
GIANNI, L ;
KEARNS, CM ;
GIANI, A ;
CAPRI, G ;
VIGANO, L ;
LOCATELLI, A ;
BONADONNA, G ;
EGORIN, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :180-190
[4]  
GREM JL, 1987, CANCER TREAT REP, V71, P1179
[5]   AN ENZYME-IMMUNOASSAY FOR THE DETERMINATION OF TAXOL AND TAXANES IN TAXUS SP TISSUES AND HUMAN PLASMA [J].
GROTHAUS, PG ;
RAYBOULD, TJG ;
BIGNAMI, GS ;
LAZO, CB ;
BYRNES, JB .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 158 (01) :5-15
[6]   PHASE-II TRIAL OF TAXOL, AN ACTIVE-DRUG IN THE TREATMENT OF METASTATIC BREAST-CANCER [J].
HOLMES, FA ;
WALTERS, RS ;
THERIAULT, RL ;
FORMAN, AD ;
NEWTON, LK ;
RABER, MN ;
BUZDAR, AU ;
FRYE, DK ;
HORTOBAGYI, GN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (24) :1797-1805
[7]   Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography [J].
Huizing, MT ;
Sparreboom, A ;
Rosing, H ;
vanTellingen, O ;
Pinedo, HM ;
Beijnen, JH .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 674 (02) :261-268
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURES FOR THE QUANTITATIVE-DETERMINATION OF PACLITAXEL (TAXOL) IN HUMAN URINE [J].
HUIZING, MT ;
ROSING, H ;
KOOPMAN, F ;
KEUNG, ACF ;
PINEDO, HM ;
BEIJNEN, JH .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 664 (02) :373-382
[9]   STEADY-STATE PLASMA-CONCENTRATIONS AND EFFECTS OF TAXOL FOR A 250-MG/M(2) DOSE IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH OVARIAN-CANCER [J].
JAMISDOW, CA ;
KLECKER, RW ;
SAROSY, G ;
REED, E ;
COLLINS, JM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (01) :48-52
[10]   PACLITAXEL (TAXOL) [J].
KOHLER, DR ;
GOLDSPIEL, BR .
PHARMACOTHERAPY, 1994, 14 (01) :3-34